The Joint (US:JYNT) ZACKS·2025-05-08 23:20分组1 - The Joint Corp. reported a quarterly loss of $0.03 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.02, and a decline from earnings of $0.06 per share a year ago, representing an earnings surprise of -50% [1] - The company posted revenues of $13.08 million for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 2.53%, but down from $29.72 million in the same quarter last year [2] - The Joint has not surpassed consensus EPS estimates over the last four quarters, although it has topped consensus revenue estimates three times during that period [2] 分组2 - The stock has underperformed the market, losing about 6.5% since the beginning of the year compared to the S&P 500's decline of -4.3% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.04 on revenues of $13.66 million, and for the current fiscal year, it is $0.13 on revenues of $57.48 million [7] - The Medical - HMOs industry, to which The Joint belongs, is currently ranked in the top 28% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]